Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical data across two major ...

CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...

Beyond the physical, a prostate cancer diagnosis carries significant emotional weight. Understanding this spectrum of ...

Struggling with BPH symptoms? Explore UroLift, a patient-friendly, day-care prostate treatment that avoids major surgery and ...

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

A radiation oncology nurse explains the spectrum of side effects that can come with radiation for prostate cancer. For patients with prostate cancer undergoing radiation, the side effect burden exists ...

Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has ...